R. Marshall

Osimertinib plus platinum–pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study

P. Jänne, D. Planchard, S. Kim, 2021, ESMO open.

Accuracy of self-reported tobacco use in newly diagnosed cancer

R. Marshall, A. Romano, W. Warren, 2013 .

Lymphoedema in patients treated for head and neck cancer and referral patterns to lymphoedema treatment services: a retrospective audit of electronic medical records

G. Buckley, R. Marshall, Erin Mercieca, 2022, The Australian Journal of Cancer Nursing.